Weight Health
Understand who starts, stays, stops, switches and returns across the Weight Health landscape.
Why Therapy Intelligence™
The intelligence your teams actually need
Leveraging real-world patient data, our Therapy Intelligence™ solution goes beyond syndicated studies to deliver
fast, robust, multi-country insights, whether used standalone or integrated with custom methodologies.
Ready in days
Data already collected. Access study extracts immediately, full data within days of your request.
Physician & Expert-Informed Design
Built on real-world patient evidence, physician expertise and evolving market needs to ensure scientific rigor and business relevance.
Fully customizable analysis
The analysis is yours to shape. Tell us what questions matter to your strategy and we tailor the outputs accordingly.
Trusted by Top 15 Global Pharma Companies
Study Scope
The questions that matter in Weight Health
Our Weight Health Therapy Intelligence covers the full GLP-1 treatment journey, from patient segmentation and treatment initiation through access, persistence and switching, including the drivers behind adoption, the routes patients use to access care, and future demand scenarios such as treatment format and affordability preferences. Modules can be tailored to your research questions.
1k+
Patient respondents
1
Countries covered
Who is actually moving into GLP-1 treatment and how do current, former and lapsed users differ by country and segment?
What really activates or blocks treatment initiation, from information sources to affordability concerns?
Where and how are patients accessing care - through prescribers, telehealth, online pharmacies or cash-pay routes?
Why do patients stay on GLP-1 therapy, and what drives dose changes over time?
Why do patients stop or restart treatment, and how common is switching between therapies?
Which future scenarios (oral vs. injectable preference, affordability, support needs) will shape future demand?
Clinical Truth to Business Impact
From the lab to the boardroom
Growth Lever
Message
Application
Identify growth opportunities
Identify untapped patient segments, hidden demand pools and future treatment opportunities across the Weight Health landscape.
e.g. Adults interested in GLP-1 treatment who have not yet initiated therapy
Refine your positioning
See where the brand wins, where it stalls and how the competitive frame should evolve
e.g. Positioning versus emerging oral GLP-1 formulations
Activate the right HCPs
Map how patients access care - HCP, telehealth, online pharmacy or private care - and where affordability shapes the journey, to know where adoption support is most needed
e.g. HCP vs. telehealth vs. online pharmacy routes patients rely on most, and where affordability drives hesitancy
Anticipate market evolution
Track launches, sequence changes, access shifts and new behaviors earlier
e.g. Shifting demand as oral vs. injectable preferences evolve
Let's Talk
Paul Taylor
Strategic Partnership Director
Manuel Guzman Martin
Vice President Commercial Global
Mélanie Marrot, PhD
Vice President Commercial France
